{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T21:36:37Z","timestamp":1778448997984,"version":"3.51.4"},"posted":{"date-parts":[[2025,7,14]]},"group-title":"In Review","reference-count":86,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,17]]},"abstract":"<title>Abstract<\/title>\n        <p>We report the largest genome-wide association study meta-analysis in ankylosing spondylitis (AS) to date (25,645 cases, 71,224 controls), identifying 27 novel loci and 86 independent genetic associations. Variations in <italic>FUT2<\/italic> (non-secretor status) and <italic>ABO<\/italic> (blood group A) increase AS risk, with Mendelian randomisation (MR) linking non-secretor status to increased AS risk from reduced gut carriage of <italic>Ruminococcus torques<\/italic>. Associations with three telomerase maintenance genes (<italic>TERT, TERC<\/italic>, <italic>RTEL1<\/italic>), and MR analysis, suggest increased telomere length causally increases AS susceptibility. Fine-mapping prioritised likely causal variants at multiple loci. Transcriptome- and proteome-wide association studies implicated 644 genes, highlighting immune-related pathways. Lower genetically-determined IL-6 and IL-12, and similar IL-23, levels were found in AS cases, offering a genetic explanation for the failure of IL-6, IL-12, and IL-23 inhibition in AS treatment. Finally, multi-omic analyses showed chromosome 2p15 association acts via reduced <italic>B3GNT2<\/italic> expression. These findings deepen understanding of AS pathogenesis, highlighting new pathways and therapeutic opportunities.<\/p>","DOI":"10.21203\/rs.3.rs-6917334\/v1","type":"posted-content","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T11:02:23Z","timestamp":1752490943000},"source":"Crossref","is-referenced-by-count":1,"title":["Multi-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibility"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-8211","authenticated-orcid":false,"given":"Matthew","family":"Brown","sequence":"first","affiliation":[{"name":"King's College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiu","family":"Li","sequence":"additional","affiliation":[{"name":"School of Public Health and Emergency Management, Southern University of Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rhuematology and Immunology, Shanghai Changzeng Hospital, The Second Military Medical University, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Harvey","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King\u2019s College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Garrido-Mesa","sequence":"additional","affiliation":[{"name":"Unidad investigaci\u00f3n cl\u00ednica de c\u00e1ncer de pulm\u00f3n, H12O-CNIO, Instituto de Investigaci\u00f3n Hospital 12 de Octubre\/Centro Nacional de Investigaciones Oncol\u00f3gica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, National key laboratory for Immunity and Inflammation, Shanghai Changzheng Hospital, Naval Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Public Health and Emergency Management, Southern University of Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2478-2919","authenticated-orcid":false,"given":"Geng","family":"Wang","sequence":"additional","affiliation":[{"name":"The University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9683-3407","authenticated-orcid":false,"given":"Helena","family":"Marzo-Ortega","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, University of Leeds"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1109-624X","authenticated-orcid":false,"given":"Ann","family":"Morgan","sequence":"additional","affiliation":[{"name":"Leeds University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-171X","authenticated-orcid":false,"given":"Nurullah","family":"Akkoc","sequence":"additional","affiliation":[{"name":"Dokuz Eyl\u00fcl University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokce Kenar","family":"Artin","sequence":"additional","affiliation":[{"name":"School of Medicine, Division of Rheumatology, Dokuz Eyl\u00fcl University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Macfarlane","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry, University of Aberdeen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Jones","sequence":"additional","affiliation":[{"name":"University of Aberdeen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Bradbury","sequence":"additional","affiliation":[{"name":"Queensland University of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Leo","sequence":"additional","affiliation":[{"name":"QUT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Queensland University of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Duncan","sequence":"additional","affiliation":[{"name":"University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Brown","sequence":"additional","affiliation":[{"name":"College of Medicine and Dentistry, James Cook University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0844-8726","authenticated-orcid":false,"given":"Tony","family":"Merriman","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Stebbings","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dunedin School of Medicine, University of Otago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[{"name":"Research Center for Chronic Inflammatory Diseases, Tehran University of Medical Sciences and Rheumatology Research Center, Tehran University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[{"name":"Research Center for Chronic Inflammatory Diseases, Tehran University of Medical Sciences and Rheumatology Research Center, Tehran University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[{"name":"Research Center for Chronic Inflammatory Diseases, Tehran University of Medical Sciences and Rheumatology Research Center, Tehran University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigil","family":"Haroon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University Health Network, University of Toronto, Schroeder Arthritis Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Inman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University Health Network, University of Toronto, Schroeder Arthritis Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-9395","authenticated-orcid":false,"given":"Maxime","family":"Breban","sequence":"additional","affiliation":[{"name":"UMR1173, Universit\u00e9 Paris Saclay, Universit\u00e9 de Versailles St Quentin en Yvelines, Inserm, Infection et Inflammation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gensler","family":"Lianne","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ward","sequence":"additional","affiliation":[{"name":"National Institutes of Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wordsworth","sequence":"additional","affiliation":[{"name":"Botnar Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weisman","sequence":"additional","affiliation":[{"name":"Stanford University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0663-4621","authenticated-orcid":false,"given":"David","family":"Evans","sequence":"additional","affiliation":[{"name":"University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Kenna","sequence":"additional","affiliation":[{"name":"Queensland University of Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-2276","authenticated-orcid":false,"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Hanyang University Hospital for Rheumatic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Reveille","sequence":"additional","affiliation":[{"name":"Memorial Hermann Texas Medical Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huji","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, National Key Laboratory for Immunity and Inflammation, Shanghai Changzheng Hospital, Naval Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. van der Linden, S.M., Valkenburg, H.A., de Jongh, B.M. & Cats, A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27, 241-9 (1984).","DOI":"10.1002\/art.1780270301"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Akkoc, N. & Khan, M.A. Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al. Arthritis Rheum 52, 4048-9; author reply 4049-50 (2005).","DOI":"10.1002\/art.21492"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Li, Z. et al. HLA-B27, axial spondyloarthritis and survival. Ann Rheum Dis 82, 1558\u20131567 (2023).","DOI":"10.1136\/ard-2023-224434"},{"key":"ref4","unstructured":"4. Mielants, H. et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 22, 2273-8 (1995)."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Jayson, M.I., Salmon, P.R. & Harrison, W.J. Inflammatory bowel disease in ankylosing spondylitis. Gut 11, 506\u2009\u2212\u200911 (1970).","DOI":"10.1136\/gut.11.6.506"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Moller, P., Vinje, O., Kass, E. & Berg, K. The distribution of clinical findings in Bechterew's syndrome (ankylosing spondylitis) suggests distinct genetic subgroups. Clin Genet 22, 151-9 (1982).","DOI":"10.1111\/j.1399-0004.1982.tb01428.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Brown, M.A., Laval, S.H., Brophy, S. & Calin, A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 59, 883-6 (2000).","DOI":"10.1136\/ard.59.11.883"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Brown, M.A. et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40, 1823-8 (1997).","DOI":"10.1002\/art.1780401015"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Pedersen, O.B. et al. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol 37, 120-6 (2008).","DOI":"10.1080\/03009740701824613"},{"key":"ref10","unstructured":"10. Cortes, A. et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat Commun 6, 7146 (2015)."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Wang, G. et al. MHC associations of ankylosing spondylitis in East Asians are complex and involve non-HLA-B27 HLA contributions. Arthritis Res Ther 22, 74 (2020).","DOI":"10.1186\/s13075-020-02148-5"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Kim, K. et al. An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population. Arthritis Res Ther 17, 342 (2015).","DOI":"10.1186\/s13075-015-0855-3"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Burton, P.R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39, 1329-37 (2007).","DOI":"10.1038\/ng.2007.17"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Danoy, P. et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet 6, e1001195 (2010).","DOI":"10.1371\/journal.pgen.1001195"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Reveille, J.D. et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42, 123-7 (2010).","DOI":"10.1038\/ng.513"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Evans, D.M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43, 761-7 (2011).","DOI":"10.1038\/ng0911-919a"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Li, Z. et al. Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis. PLoS Genet 15, e1008038 (2019).","DOI":"10.1371\/journal.pgen.1008038"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet 48, 510-8 (2016).","DOI":"10.1038\/ng.3528"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Yuan, K. et al. Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases. Nat Genet 56, 1841\u20131850 (2024).","DOI":"10.1038\/s41588-024-01870-z"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Sivanesan, D. et al. IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking. J Biol Chem 291, 8673-85 (2016).","DOI":"10.1074\/jbc.M116.715870"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Couturier, N. et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 134, 693\u2013703 (2011).","DOI":"10.1093\/brain\/awr010"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Parkes, M., Cortes, A., van Heel, D.A. & Brown, M.A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 14, 661\u2009\u2212\u200973 (2013).","DOI":"10.1038\/nrg3502"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Donnelly, S. et al. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Annals of the rheumatic diseases 53, 117\u2009\u2212\u200921 (1994).","DOI":"10.1136\/ard.53.2.117"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Toussirot, E., Michel, F. & Wendling, D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) 40, 882-8 (2001).","DOI":"10.1093\/rheumatology\/40.8.882"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Feng, W. et al. NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing. Nat Commun 14, 7238 (2023).","DOI":"10.1038\/s41467-023-42834-x"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Costantino, F. et al. ERAP1 Gene Expression Is Influenced by Nonsynonymous Polymorphisms Associated With Predisposition to Spondyloarthritis. Arthritis Rheumatol 67, 1525-34 (2015).","DOI":"10.1002\/art.39072"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Hanson, A.L. et al. Genetic Variants in ERAP1 and ERAP2 Associated With Immune-Mediated Diseases Influence Protein Expression and the Isoform Profile. Arthritis Rheumatol 70, 255\u2013265 (2018).","DOI":"10.1002\/art.40369"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Nelson, M.R. et al. The support of human genetic evidence for approved drug indications. Nat Genet 47, 856\u2009\u2212\u200960 (2015).","DOI":"10.1038\/ng.3314"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Sieper, J., Porter-Brown, B., Thompson, L., Harari, O. & Dougados, M. Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Ann Rheum Dis 73, 95\u2013100 (2014).","DOI":"10.1136\/annrheumdis-2013-203559"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Sieper, J. et al. Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN). Ann Rheum Dis 74, 1051-7 (2015).","DOI":"10.1136\/annrheumdis-2013-204963"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Deodhar, A. et al. Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis. Arthritis Rheumatol 71, 258\u2013270 (2019).","DOI":"10.1002\/art.40728"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Baeten, D. et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann Rheum Dis 77, 1295\u20131302 (2018).","DOI":"10.1136\/annrheumdis-2018-213328"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Gratacos, J. et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33, 927\u2009\u2212\u200931 (1994).","DOI":"10.1093\/rheumatology\/33.10.927"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Tsui, F.W.L. et al. Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis. Arthritis Res Ther 23, 141 (2021).","DOI":"10.1186\/s13075-021-02521-y"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Lin, T.T. et al. Elevated serum level of IL-27 and VEGF in patients with ankylosing spondylitis and associate with disease activity. Clin Exp Med 15, 227\u2009\u2212\u200931 (2015).","DOI":"10.1007\/s10238-014-0281-x"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Jouhault, Q. et al. Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses. Front Immunol 13, 1072420 (2022).","DOI":"10.3389\/fimmu.2022.1072420"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Kurilshikov, A. et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 53, 156\u2013165 (2021).","DOI":"10.1038\/s41588-020-00763-1"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Stoll, M.L. et al. The faecal microbiota is distinct in HLA-B27\u2009+\u2009ankylosing spondylitis patients versus HLA-B27\u2009+\u2009healthy controls. Clin Exp Rheumatol 41, 1096\u20131104 (2023).","DOI":"10.55563\/clinexprheumatol\/nlsj0o"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Baeten, D. et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382, 1705-13 (2013).","DOI":"10.1016\/S0140-6736(13)61134-4"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. Kerschbaumer, A. et al. Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 83, 760\u2013774 (2024).","DOI":"10.1136\/ard-2024-225534"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Gracey, E. et al. TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis. J Clin Invest 130, 1863\u20131878 (2020).","DOI":"10.1172\/JCI126567"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"42. Costello, M.E. et al. Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis. Arthritis Rheumatol 67, 686\u2013691 (2015).","DOI":"10.1002\/art.38967"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"43. Yin, J. et al. Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition. Ann Rheum Dis 79, 132\u2013140 (2020).","DOI":"10.1136\/annrheumdis-2019-215763"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"44. Breban, M. et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis 76, 1614\u20131622 (2017).","DOI":"10.1136\/annrheumdis-2016-211064"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. Tito, R.Y. et al. Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis. Arthritis Rheumatol 69, 114\u2013121 (2017).","DOI":"10.1002\/art.39802"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"46. Sternes, P.R. et al. Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity. Arthritis Res Ther 24, 163 (2022).","DOI":"10.1186\/s13075-022-02853-3"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"47. Li, Z. et al. Epigenetic and gene expression analysis of ankylosing spondylitis-associated loci implicate immune cells and the gut in the disease pathogenesis. Genes Immun 18, 135\u2013143 (2017).","DOI":"10.1038\/gene.2017.11"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"48. Ruhlemann, M.C. et al. Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome. Nat Genet 53, 147\u2013155 (2021).","DOI":"10.1038\/s41588-020-00747-1"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"49. Wacklin, P. et al. Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One 6, e20113 (2011).","DOI":"10.1371\/journal.pone.0020113"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"50. Lopera-Maya, E.A. et al. Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project. Nat Genet 54, 143\u2013151 (2022).","DOI":"10.1038\/s41588-021-00992-y"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"51. Liu, G., Hao, Y., Yang, Q. & Deng, S. The Association of Fecal Microbiota in Ankylosing Spondylitis Cases with C-Reactive Protein and Erythrocyte Sedimentation Rate. Mediators Inflamm 2020, 8884324 (2020).","DOI":"10.1155\/2020\/8884324"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"52. Chen, Z. et al. Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis. Ann Transl Med 7, 571 (2019).","DOI":"10.21037\/atm.2019.09.41"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"53. Png, C.W. et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105, 2420-8 (2010).","DOI":"10.1038\/ajg.2010.281"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"54. Schaus, S.R. et al. Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by Bacteroides thetaiotaomicron. mBio 15, e0003924 (2024).","DOI":"10.1128\/mbio.00039-24"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"55. Tamayo, M. et al. Differing patterns of peripheral blood leukocyte telomere length in rheumatologic diseases. Mutat Res 683, 68\u201373 (2010).","DOI":"10.1016\/j.mrfmmm.2009.10.010"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"56. Fessler, J. et al. Premature senescence of T-cell subsets in axial spondyloarthritis. Ann Rheum Dis 75, 748\u2009\u2212\u200954 (2016).","DOI":"10.1136\/annrheumdis-2014-206119"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"57. Liu, M. et al. Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study. Front Genet 14, 1129247 (2023).","DOI":"10.3389\/fgene.2023.1129247"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"58. Wei, D. et al. Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: A bidirectional Mendelian randomization study. Front Immunol 14, 1023991 (2023).","DOI":"10.3389\/fimmu.2023.1023991"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"59. Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-31 (2008).","DOI":"10.1016\/j.cell.2008.03.039"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"60. Ziv, A. et al. An RTEL1 Mutation Links to Infantile-Onset Ulcerative Colitis and Severe Immunodeficiency. J Clin Immunol 40, 1010\u20131019 (2020).","DOI":"10.1007\/s10875-020-00829-z"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"61. Luo, Q. et al. Exploration of the potential causative genes for inflammatory bowel disease: Transcriptome-wide association analysis, Mendelian randomization analysis and Bayesian colocalisation. Heliyon 10, e28944 (2024).","DOI":"10.1016\/j.heliyon.2024.e28944"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"62. Medina-Neira, D. et al. Hemophagocytic lymphohistiocytosis as the initial manifestation of bone marrow failure in a child with a TERC variant telomere biology disorder. Ther Adv Rare Dis 6, 26330040241311621 (2025).","DOI":"10.1177\/26330040241311621"},{"key":"ref63","unstructured":"63. Aterido, A. et al. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. Ann Rheum Dis 78(2019)."},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"64. Liu, J.Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47, 979\u2013986 (2015).","DOI":"10.1038\/ng.3359"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"65. Robinson, P.C. et al. Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheumatol 67, 140\u2009\u2212\u200951 (2015).","DOI":"10.1002\/art.38873"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"66. Kiryluk, K. et al. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet 55, 1091\u20131105 (2023).","DOI":"10.1038\/s41588-023-01422-x"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"67. Bang, S.Y. et al. Genetic Studies of Ankylosing Spondylitis in Koreans Confirm Associations with ERAP1 and 2p15 Reported in White Patients. J Rheumatol (2010).","DOI":"10.3899\/jrheum.100652"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"68. Davidson, S.I. et al. Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 70, 289\u2009\u2212\u200992 (2011).","DOI":"10.1136\/ard.2010.133322"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"69. Wang, C.M. et al. Genetic effects of B3GNT2 on ankylosing spondylitis susceptibility and clinical manifestations in Taiwanese. J Formos Med Assoc 121, 1283\u20131294 (2022).","DOI":"10.1016\/j.jfma.2021.09.010"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"70. Togayachi, A. et al. Beta3GnT2 (B3GNT2), a major polylactosamine synthase: analysis of B3GNT2-deficient mice. Methods Enzymol 479, 185\u2013204 (2010).","DOI":"10.1016\/S0076-6879(10)79011-X"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"71. Joung, J. et al. CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. Nat Commun 13, 1606 (2022).","DOI":"10.1038\/s41467-022-29205-8"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"72. Duncan, E., Cardon, L., Sinsheimer, J., Wass, J. & Brown, M. Site and Gender Specificity of Inheritance of Bone Mineral Density. J Bone Miner Res 18, 1531\u20131538 (2003).","DOI":"10.1359\/jbmr.2003.18.8.1531"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"73. Kiel, D.P. et al. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 8 Suppl 1, S14 (2007).","DOI":"10.1186\/1471-2350-8-S1-S14"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"74. Will, R., Palmer, R., Bhalla, A.K., Ring, F. & Calin, A. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2, 1483-5 (1989).","DOI":"10.1016\/S0140-6736(89)92932-2"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"75. Schett, G. et al. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol 13, 731\u2013741 (2017).","DOI":"10.1038\/nrrheum.2017.188"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"76. van der Linden, S., Valkenburg, H.A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27, 361-8 (1984).","DOI":"10.1002\/art.1780270401"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"77. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559\u2009\u2212\u200975 (2007).","DOI":"10.1086\/519795"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"78. Cuellar-Partida, G. et al. Complex-Traits Genetics Virtual Lab: A community-driven web platform for post-GWAS analyses. BioRxiv (2019).","DOI":"10.1101\/518027"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"79. Yamamoto, F., Clausen, H., White, T., Marken, J. & Hakomori, S. Molecular genetic basis of the histo-blood group ABO system. Nature 345, 229\u2009\u2212\u200933 (1990).","DOI":"10.1038\/345229a0"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"80. Daniels, G. Human Blood Groups, (Wiley-Blackwell, Chichester, 2013).","DOI":"10.1002\/9781118493595"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"81. McRae, A.F. et al. Identification of 55,000 Replicated DNA Methylation QTL. Sci Rep 8, 17605 (2018).","DOI":"10.1038\/s41598-018-35871-w"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"82. Codd, V. et al. Polygenic basis and biomedical consequences of telomere length variation. Nat Genet 53, 1425\u20131433 (2021).","DOI":"10.1038\/s41588-021-00944-6"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"83. Bowden, J. et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36, 1783\u20131802 (2017).","DOI":"10.1002\/sim.7221"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"84. Sanna, S. et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 51, 600\u2013605 (2019).","DOI":"10.1038\/s41588-019-0350-x"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"85. Law, C.W. et al. RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR. F1000Res 5(2016).","DOI":"10.12688\/f1000research.9005.2"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"86. Ritchie, M.E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47 (2015).","DOI":"10.1093\/nar\/gkv007"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6917334\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6917334\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T11:02:37Z","timestamp":1752490957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6917334\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":86,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6917334\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,7,14]]},"subtype":"preprint"}}